VIVO Initiated Coverage by Noble Capital Markets -- Rating Set to Outperform

Vivos Therapeutics price target lowered by $1 at Alliance Global, here's why

See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F

Green Stocks July 6- Green Pack Sees Some Profit Booking

On a day with a firm market, the green pack took a pause as profit booking rose to the fore in many stocks that have risen to highs in the p

Palantir Stock: Accelerating Growth Improves the Risk-Reward Profile

Dixon Technologies Gets Vivo JV Boost! Buy, Sell Or Hold? Expert Explains

Dixon Technologies is back in the spotlight after receiving government approval for its long-awaited joint venture with Vivo India. The part

Wall Street sees more gains ahead for this SpaceX supplier

A slew of Wall Street analysts initiated coverage of Applied Aerospace & Defense at an outperform- or buy-equivalent rating.

VivoSim Labs (NASDAQ:VIVS) hits $5M milestone; company says 500% revenue jump comes off $131K base

SAN DIEGO, July 15, 2026, 13:07 (PDT) Lilly’s payment is 38.2 times VivoSim’s 2026 fiscal revenue, and about 1.7 times the company’s closing